Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HPV Testing Versus Cytology for Cervical Cancer Screening Among Women 50 Years and Older: Evidence From the HPV FOCAL Randomized Controlled Trial.

International journal of cancer·2026
Same author

Diversity, equity, and inclusion as scientific rigor: progress during challenging times.

Journal of the National Cancer Institute·2026
Same author

Diversity, equity, and inclusion as scientific rigor: progress during challenging times.

JNCI cancer spectrum·2026
Same author

Impact of switching from a quadrivalent to a nonavalent HPV vaccine on HPV infections and cervical cancer in Colombia: a mathematical modelling study.

Lancet regional health. Americas·2026
Same author

HPV Prevalence Among Inuit Women in Northern Quebec, Canada: A Pre- and Post-Vaccination Analysis.

Journal of lower genital tract disease·2026
Same author

Correction: ​​Enhancing the sensitivity of non-invasive cervical cancer detection using CpG methylation haplotype profiling.

Scientific reports·2026

Related Experiment Video

Updated: Mar 29, 2026

Transperineal Prostate Biopsy Using a Cone-shaped Double-hole Method with Dual-plane Probe Guidance
05:35

Transperineal Prostate Biopsy Using a Cone-shaped Double-hole Method with Dual-plane Probe Guidance

Published on: June 6, 2025

2.2K

Optimizing technology for cervical cancer screening in high-resource settings.

Lyndsay A Richardson1, Joseph Tota1, Eduardo L Franco1

  • 1Division of Cancer Epidemiology, McGill University, 546 Pine Avenue West, Montreal, QC, H2W 1S6, Canada.

Expert Review of Obstetrics & Gynecology
|December 1, 2015
PubMed
Summary

Primary screening for high-risk human papillomavirus (HPV) infection offers greater sensitivity for cervical cancer detection than traditional Pap tests. Combining HPV testing with Pap cytology for triage ensures accurate diagnosis and management.

Keywords:
Papanicolaou testcervical cancerhuman papillomavirushuman papillomavirus vaccinemass screeningtest performance

More Related Videos

Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications
14:14

Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications

Published on: February 28, 2014

16.4K
Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

11.5K

Related Experiment Videos

Last Updated: Mar 29, 2026

Transperineal Prostate Biopsy Using a Cone-shaped Double-hole Method with Dual-plane Probe Guidance
05:35

Transperineal Prostate Biopsy Using a Cone-shaped Double-hole Method with Dual-plane Probe Guidance

Published on: June 6, 2025

2.2K
Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications
14:14

Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications

Published on: February 28, 2014

16.4K
Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

11.5K

Area of Science:

  • Gynecology
  • Oncology
  • Infectious Diseases

Background:

  • Papanicolaou (Pap) testing has historically reduced cervical cancer burden but has limitations.
  • High-risk human papillomavirus (HPV) infection is the primary cause of cervical cancer.
  • Modern screening strategies are evolving to incorporate HPV detection.

Purpose of the Study:

  • To evaluate the benefits of primary screening for high-risk HPV infections in cervical cancer detection.
  • To assess the role of Pap cytology in triaging HPV-positive cases.
  • To explore the integration of novel HPV screening technologies.

Main Methods:

  • Utilizing molecular tests for HPV nucleic acid detection for high sensitivity.
  • Employing Pap cytology for high specificity in triaging HPV-positive individuals.
  • Analyzing an algorithm of primary HPV testing with Pap triage.

Main Results:

  • Primary HPV testing demonstrates higher sensitivity compared to Pap testing.
  • Pap cytology effectively rules out false positives in HPV-positive cases.
  • The primary HPV testing with Pap triage algorithm maintains high sensitivity and specificity.

Conclusions:

  • Primary HPV testing is a more sensitive approach for cervical cancer screening.
  • Integrating HPV testing with Pap cytology offers a robust screening strategy.
  • Future challenges include incorporating novel HPV gene expression technologies into clinical practice.